reiter ow pg result
head shoulder
robust top-line result support view pg organ
sale growth trajectori sustain improv
combin inflect gross margin drive
strong high qualiti quarter follow substanti top-line ep beat vs
fiscal consensu pg stock rose vs strong
un-round organ sale growth vs market
expect gross margin inflect bp yoy bp
consensu off-set greater expect reinvest profit line
ep bolster profit line item includ lower tax rate
top-line strength driven above-consensu sale nearli everi divis
pg best organ sale growth year pg gross margin increas
bp y-o-i also best result far us cpg ep season
bp bp cl growth led health
fabric beauti broad-bas
pg global categori gain hold share weight average market
share gain bp y-o-i vs bp last quarter bp four quarter trail
averag untrack channel growth particularli strong organ
sale growth e-commerc sale mix strong club channel
trend along broad base strength across pg portfolio confid
tone growth outlook pg construct hpc industri
environ given healthi market top-line growth price realiz
improv evid pg result hpc industri broadli
promot intens y-o-i basi particularli us
categori level index vs prior year pg price
like dissip pg cycl increas promot pick
lower commod sound like price environ remain
ration far net result give us greater convict call pg
organ top-line growth sustain rebound gm inflect
household person unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
key driver ow thesi see pg stock still compel
discount price-to-earnings cl despit clearli superior lt topline/ep growth
mind
rais ep estim initi guidanc strong result
rais ep upper half pg rang
pt increas due higher ep increas multipl
given greater confid higher pg growth peer
detail pg core ep consensu mse
high qualiti larg top-line upsid robust unround
round organ sale growth bp gm beat mostli off-set
greater expect sg drive in-lin profit beat vs consensu
ep upsid driven profit line item includ lower tax rate
flatter ep cent vs model organ sale growth
un-round came far ahead consensu street
expect two-year averag growth also acceler vs
first three quarter top-line growth balanc price
volum mix price improv sequenti vs
flat y-o-i declin report top-line
beat boost better expect gross margin expand larg
bp yoy includ bp fx bp product bp
price bp commod bp unfavor product mix
bp innov reinvest sg sale
decreas bp yoy wors bp consensu larg driven
reinvest includ bp unfavor fx bp sale
leverag bp market expens overhead save bp
gain boston real estat bp market reinvest bp
capabl invest sale higher compens cost
bp merck over-the-counter cost net oper profit beat consensu
om bp y-o-i pg clearli reinvest gross profit upsid
strong segment result pg result strong across segment upsid
vs consensu segment beauti strong volum price
mix vs consensu skin person organ sale
mid-teen driven growth super-premium sk-ii brand olay skin
increas price hair organ sale increas lsd
volum price mix vs consensu
person mid-teen due innov late season increas
cough cold incid favor mix due higher growth develop
region oral hsd premium innov posit mix fabric
 volum price mix vs consensu
dd growth fabric babi feminin
famili organ sale volum price mix vs
consensu babi increas lsd due devaluation-rel price
increas posit mix growth premium product partial off-set
reduc volum due increas price competit activ categori
contract certain market feminin organ sale increas hsd
famili organ sale increas msd groom volum
price mix vs consensu
initi guidanc pg provid initi organ sale growth guidanc
all-in sale growth includ modest neg
impact fx larg off-set posit impact acquisit
divestitur compani expect core ep growth wider usual
rang base impli midpoint
prior consensu mse seemingli
realist high-end consensu pg earn guidanc incorpor
modest net benefit commod foreign exchang transport
tariff pg expect core effect tax rate rang
adjust free cash flow product better billion
dividend repurchas billion common share capit spend
ar sale
gillett impair pg took after-tax non-cash impair charg
adjust carri valu goodwil trade name intang asset
gillett shave busi primarili due signific currenc devalu
occur sinc deal close well neg impact
market contract blade razor develop market due lower
shave frequenc competit activ pg indic shave busi
continu strateg busi
exhibit pg organ sale growth acceler
exhibit led improv categori growth moder market share
deriv base case scenario
top-line rebound organ sale growth revenu upsid bp int
upsid bp us upsid pg marketing/innov focu drive
market share improv cut forecast better
expect price realiz drive margin upsid turn ep growth
valuat expand ep
go forward hpc peer led improv us result
build market share momentum better price realiz continu cost
save support bp om expansion/yr drive hsd ep growth
appli multipl ep slight premium pg average given
us led topline/margin downsid us bear case scenario play
bp pricing/volum downsid along bp margin downsid greater
reinvest outsid us bp top-line downsid bp
margin downsid drive mute lsd ep growth valuat contract
believ strategi tweak put place recent
year bear fruit acceler pg
top-line growth back rang
us improv breadth perform
reduc promot intens give us
confid market share momentum
sustain combin
improv price outlook greater agil
organiz chang implement
support top-line growth hpc peer
year fy gross margin declin see fy
gm inflect led improv price
realiz less oner commod
headwind combin sizabl cost
save program worth annual
profit see scope bp annual
margin expans turn hsd
ep growth deliveri next sever
valuat look compel rel
basi pg trade ep
discount hpc peer cl rel
valuat look compel consid
call pg fundament posit inflect
year under-perform vs
risk achiev price
market share vacil currenc
exhibit bear bull top-line trend stock driver
valu
sale
sale
sale bp chang
sale
sale bp chang
prepaid expens current asset
note loan payabl
current portion long-term debt
accru liabil
reserv esop debt retir
depreci amort
chang a/l
a/p accru liabil
oper asset liabil
provid oper
flow invest activ
proce asset sale
payment acquisit
use invest activ
flow financ activit
chang short-term debt
chang long-term debt
purchas treasuri share
use financ activ
provid discontinu oper
exchang rate effect
net increas decreas equiv
equiv beg
equiv end
